This Solicitation opportunity from Department Of Defense was posted on September 1, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
BACITRACIN OINTMENT
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
Solicitation SPE2DP-26-T-4828 is a fixed-price, small business set-aside request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Bacitracin Ointment. The requirement consists of 17 boxes of 0.9 gram packets, with each box containing 144 units. The product is identified by NSN 6505-01-671-4147 and must be stored at medical controlled room temperature. The items are to be delivered FOB Destination to the Medical Logistics facility at Fort Bragg, North Carolina, within 20 days after the order is placed. The contract mandates strict adherence to quality and packaging standards, including the DLA Master List of Technical and Quality Requirements, MIL-STD-129 for marking, and the Medical Marking Standard No. 1. Non-hazardous materials must be commercially packaged per ASTM D3951, while hazardous materials require packaging according to TQ requirement IP025 and FED-STD-313. Palletization must comply with RP001. The item is classified as a Type 2 (Code 9) item with an extendable shelf life of 60 months. Invoicing and payment must be processed electronically through the Wide Area WorkFlow system.
General Info
Place of Performance
BLD A5474 PRATT ST, FORT BRAGG, NC, 28310, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
BACITRACIN OINTMENT 0.9 GRAM PACKETS
144 PER BOX UNIT OF ISSUE
STORE AT MEDICAL CONTROLLED ROOM TEMPERATURE
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS062: Shelf life requirement RS001 for a TYPE 2 (CODE 9) item with a shelf life of 60 month (extendable) applies to this item.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
COMBAT MEDICAL SYSTEMS LLC 515E6 P/N WJBA1728-BX
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018127576 0001 BX 17.000
NSN/MATERIAL:6505016714147
SPE2DP-26-T-4828
SECTION B
PR: 7018127576 PRLI: 0001 CONT’D
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
SHIP BY TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
MARKFOR
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
M/F: (TCN) W50YF262370025
RDD: 251
PROJ: TP 3
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 12
SPE2DP-26-T-4828
SECTION B
PR: 7018127576 PRLI: 0001 CONT’D
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:09/03/2026
SPE2DP-26-T-4828 NSN/Part Number: 6505-01-671-4147 Quantity: 17 BX Purchase Request: 7018127576QTY: 17 Delivery: 20 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
